CMS has dropped measure OP-16 from the hospital outpatient quality reporting program for calendar year 2013, according to an AHA News Now report.
The measure requires hospitals to report Troponin results for heart attack and chest pain patients within 60 minutes of arrival at the hospital emergency room. The agency has removed the reporting measure following the FDA's recall of a number of point-of-care testing kits that reporting false results. The recall affected testing kits for Troponin.
As a result, participating hospitals should enter a "dummy" number into the field for measure OP-16 when submitting data for the quality reporting program.
The measure requires hospitals to report Troponin results for heart attack and chest pain patients within 60 minutes of arrival at the hospital emergency room. The agency has removed the reporting measure following the FDA's recall of a number of point-of-care testing kits that reporting false results. The recall affected testing kits for Troponin.
As a result, participating hospitals should enter a "dummy" number into the field for measure OP-16 when submitting data for the quality reporting program.
More Articles on Quality Reporting:
3 Challenges in Managing Quality Measure Information
10 Changes to Quality Reporting Programs
3 Ways Hospitals' Quality Data Can Be Misleading